CompletedN/Aketamine

Sustained Ketamine Effectiveness for Suicidal Ideation

Sponsored by University Hospital, Montpellier

NCT ID
NCT06806475
Target Enrollment
128 participants
Start Date
2023-12-01
Est. Completion
2024-09-23

About This Study

As part of the usual clinical activity of the Emergency and Post-Emergency Psychiatric Department, IV ketamine is used to treat suicidal crises in depressed patients hospitalized as an add-on to the treatment of depression. This infusion can be repeated. Patients are systematically reassessed twice in the month following the last infusion, to ensure that the suicidal crisis is progressing. Psychometric assessments are part of routine care, to ensure systematic evaluation of psychopathology, intensity of depression and suicidality. Therefore existing data were re-used from the medical records of patients who had received ketamine infusions to assess the effect of ketamine on suicidal ideation and behaviour.

Conditions Studied

Depression - Major Depressive DisorderSuicide

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Patients treated with IV ketamine in the Psychiatric Emergency and Post-Emergency Department (University Hospital, Montpellier) in context of suicidal crisis
* over 18 y.o

Exclusion Criteria:

* Opposition to data use
* Subject deprived of liberty (by judicial or administrative decision)
* Subject protected by law (guardianship or curatorship)
* Subject not affiliated to a social security system

Study Locations (1)

University Hospital, Montpellier
Montpellier, France

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Sustained Ketamine Effectiveness for Suicidal Ideation | Huxley